文献速递甲状腺核医学核素与放射性配体治疗放射性药物与辐射防护

分化型甲状腺癌患者经SPECT/CT诊断的胡须131I污染

Beard Contamination With 131 I Diagnosed by SPECT/CT in a Patient With Differentiated Thyroid Cancer.
PubMed 文献 · Clin Nucl Med · 2024-05-14

一例32岁分化型甲状腺癌男性患者行甲状腺残余组织放射性碘消融治疗后,平面全身扫描显示颈部侧面局灶性131I浓聚,经颈部SPECT/CT证实放射性活性位于患者胡须,为假阳性摄取。

要点

  • 分化型甲状腺癌患者131I治疗后平面显像见颈部侧面局灶性浓聚时,需考虑污染所致假阳性。
  • SPECT/CT可帮助明确131I局灶性摄取的解剖定位,本例定位于胡须。
  • 颈部侧面异常131I浓聚并非总提示转移,胡须污染是可能的假阳性原因之一。

核心结论

  • 分化型甲状腺癌患者131I治疗后平面全身扫描发现的颈部侧面局灶性浓聚,经SPECT/CT证实为胡须131I污染所致假阳性。

研究设计与样本

  • 病例报告:一例32岁男性分化型甲状腺癌患者,行甲状腺残余组织放射性碘消融治疗后进行平面全身扫描及颈部SPECT/CT显像。

主要发现

  • 治疗后平面全身扫描显示颈部侧面投射区可见明显131I摄取。
  • 颈部SPECT/CT扫描将放射性活性定位于患者胡须。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Abnormal focal accumulation of 131 I is generally a reliable indicator of differentiated thyroid cancer metastases. However, many examples of false-positive 131 I uptake were reported, some of them of unusual nature. We report a case of 32-year-old man with differentiated thyroid cancer who underwent thyroid remnants ablation with radioiodine. An area of considerable 131 I uptake projecting onto lateral cervical areas was detected on posttherapy planar whole-body scan. Neck SPECT/CT scan was done to elucidate localization of the uptake, and activity was found in the patient's beard.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Makarewicz J, Rudzki J. Beard Contamination With 131 I Diagnosed by SPECT/CT in a Patient With Differentiated Thyroid Cancer. Clin Nucl Med. 2024. PMID: 38768062. doi:10.1097/RLU.0000000000005282

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。